Equities Analysts Offer Predictions for Balchem Q1 Earnings

Balchem Co. (NASDAQ:BCPCFree Report) – Analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for shares of Balchem in a research report issued to clients and investors on Monday, February 24th. HC Wainwright analyst R. Selvaraju now expects that the basic materials company will earn $0.99 per share for the quarter, down from their prior estimate of $1.06. HC Wainwright currently has a “Buy” rating and a $190.00 price objective on the stock. The consensus estimate for Balchem’s current full-year earnings is $4.64 per share. HC Wainwright also issued estimates for Balchem’s Q2 2025 earnings at $1.03 EPS, Q3 2025 earnings at $1.08 EPS, Q4 2025 earnings at $1.12 EPS, FY2025 earnings at $4.22 EPS, Q1 2026 earnings at $1.13 EPS, Q2 2026 earnings at $1.17 EPS, Q3 2026 earnings at $1.20 EPS and FY2026 earnings at $4.71 EPS.

Separately, StockNews.com lowered Balchem from a “buy” rating to a “hold” rating in a report on Tuesday.

Read Our Latest Stock Analysis on Balchem

Balchem Price Performance

BCPC stock opened at $173.59 on Wednesday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. The company’s 50-day moving average is $162.01 and its 200-day moving average is $169.44. The stock has a market capitalization of $5.64 billion, a PE ratio of 44.17, a price-to-earnings-growth ratio of 4.41 and a beta of 0.69. Balchem has a 1 year low of $137.69 and a 1 year high of $186.03.

Balchem (NASDAQ:BCPCGet Free Report) last issued its earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.11 by ($0.08). Balchem had a return on equity of 11.37% and a net margin of 13.47%. The company had revenue of $240.00 million for the quarter, compared to the consensus estimate of $239.96 million.

Balchem Increases Dividend

The firm also recently declared an annual dividend, which was paid on Friday, January 17th. Shareholders of record on Thursday, December 26th were paid a dividend of $0.87 per share. This represents a yield of 0.4%. The ex-dividend date was Thursday, December 26th. This is a positive change from Balchem’s previous annual dividend of $0.79. Balchem’s payout ratio is 22.14%.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in BCPC. Quadrant Capital Group LLC increased its position in shares of Balchem by 8.2% during the fourth quarter. Quadrant Capital Group LLC now owns 989 shares of the basic materials company’s stock worth $161,000 after acquiring an additional 75 shares in the last quarter. Covestor Ltd boosted its stake in Balchem by 93.8% during the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company’s stock valued at $26,000 after purchasing an additional 76 shares during the last quarter. Arizona State Retirement System increased its holdings in Balchem by 0.8% during the 4th quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company’s stock worth $1,534,000 after purchasing an additional 77 shares in the last quarter. Vident Advisory LLC raised its stake in shares of Balchem by 6.0% in the fourth quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company’s stock worth $232,000 after purchasing an additional 80 shares during the last quarter. Finally, Mackenzie Financial Corp lifted its holdings in shares of Balchem by 2.2% in the fourth quarter. Mackenzie Financial Corp now owns 3,840 shares of the basic materials company’s stock valued at $626,000 after purchasing an additional 84 shares in the last quarter. 87.91% of the stock is owned by institutional investors.

About Balchem

(Get Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

See Also

Earnings History and Estimates for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.